(See CONTRAINDICATIONS.) Central Cranial Diabetes Insipidus: Desmopressin nasal spray solution, USP 0.01% is indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region
How to Take BPC-157: Dosage and Timing How to take BPC-157: inject 250-500 mcg subcutaneously near the injury once daily for 4-8 weeks
The principal serious adverse reactions are: (1) Ovarian hyperstimulation, a syndrome of sudden ovarian enlargement, ascites with or without pain and/or pleural effusion, (2) Rupture of ovarian cysts with resultant hemoperitoneum, (3) Multiple births and (4) Arterial thromboembolism
About 50% of men have the condition at age 50, and the percentage increases with age
But BPC-157 is a therapeutic peptide that affects tissue repair, inflammation, and cellular function throughout your body